Galena Biopharma to Present at the 8th Annual JMP Securities Healthcare Conference

Galena Biopharma to Present at the 8th Annual JMP Securities Healthcare
Conference

LAKE OSWEGO, Ore., July 2, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma
(Nasdaq:GALE), a biopharmaceutical company developing innovative, targeted
oncology treatments that address major unmet medical needs to advance cancer
care, today announced that Mark J. Ahn, Ph.D., President & CEO, will present a
corporate update at the 8^th Annual JMP Securities Healthcare Conference. The
presentation will take place on Wednesday, July 10, 2013 at 10:30 a.m. ET at
The St. Regis Hotel in New York, NY.

The presentation will be webcast and available on the Investors section of the
Company's website at www.galenabiopharma.com.

About Galena Biopharma

Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based
biopharmaceutical company developing innovative, targeted oncology treatments
that address major unmet medical needs to advance cancer care. For more
information please visit us at www.galenabiopharma.com.

CONTACT: Remy Bernarda
         Senior Director, Communications
         (503) 405-8258
         rbernarda@galenabiopharma.com

Galena Biopharma, Inc.
 
Press spacebar to pause and continue. Press esc to stop.